Oxidative Stress in Rheumatoid Arthritis: What the Future Might Hold regarding Novel Biomarkers and Add-On Therapies
Autor: | Luiza A. Rabelo, Valéria Nunes-Souza, Lucas José Sá da Fonseca, Marília O. F. Goulart |
---|---|
Rok vydání: | 2019 |
Předmět: |
musculoskeletal diseases
0301 basic medicine Aging medicine.medical_treatment Arthritis Review Article medicine.disease_cause Systemic inflammation Biochemistry Antioxidants Arthritis Rheumatoid 03 medical and health sciences 0302 clinical medicine medicine Animals Humans Endocrine system lcsh:QH573-671 Autoimmune disease Chemotherapy lcsh:Cytology business.industry Cell Biology General Medicine medicine.disease Pathophysiology Oxidative Stress 030104 developmental biology Chemotherapy Adjuvant Antirheumatic Agents 030220 oncology & carcinogenesis Rheumatoid arthritis Immunology medicine.symptom Reactive Oxygen Species business Oxidation-Reduction Biomarkers Oxidative stress |
Zdroj: | Oxidative Medicine and Cellular Longevity, Vol 2019 (2019) Oxidative Medicine and Cellular Longevity |
ISSN: | 1942-0994 1942-0900 |
DOI: | 10.1155/2019/7536805 |
Popis: | Numerous rheumatologic autoimmune diseases, among which rheumatoid arthritis, are chronic inflammatory diseases capable of inducing multiple cumulative articular and extra-articular damage, if not properly treated. Nevertheless, benign conditions may, similarly, exhibit arthritis as their major clinical finding, but with short-term duration instead, and evolve to spontaneous resolution in a few days to weeks, without permanent articular damage. Such distinction—self-limited arthritis with no need of immunosuppressive treatment or chronic arthritis at early stages?—represents one of the greatest challenges in clinical practice, once many metabolic, endocrine, neoplastic, granulomatous, infectious diseases and other autoimmune conditions may mimic rheumatoid arthritis. Indeed, the diagnosis of rheumatoid arthritis at early stages is a crucial step to a more effective mitigation of the disease-related damage. As a prototype of chronic inflammatory autoimmune disease, rheumatoid arthritis has been linked to oxidative stress, a condition in which the pool of reactive oxygen species increases over time, either by their augmented production, the reduction in antioxidant defenses, or the combination of both, ultimately implying compromise in the redox signaling. The exact mechanisms through which oxidative stress may contribute to the initiation and perpetuation of local (in the articular milieu) and systemic inflammation in rheumatoid arthritis, particularly at early stages, still remain to be determined. Furthermore, the role of antioxidants as therapeutic adjuvants in the control of disease activity seems to be overlooked, as a little number of short studies addressing this issue is currently found. Thus, the present review focuses on the binomialrheumatoid arthritis-oxidative stress, bringing insights into their pathophysiological relationships, as well as the implications of potential diagnostic oxidative stress biomarkers and therapeutic interventions directed to the oxidative status in patients with rheumatoid arthritis. |
Databáze: | OpenAIRE |
Externí odkaz: |